Endo Begins Shipment of Generic Kuvan® Tablets and Powder for Oral Solution (sapropterin dihydrochloride)
DUBLIN, Oct. 1, 2020 /CNW/ — Endo International plc (NASDAQ: ENDP) today announced that its subsidiary, Par Pharmaceutical, Inc.
DUBLIN, Oct. 1, 2020 /CNW/ — Endo International plc (NASDAQ: ENDP) today announced that its subsidiary, Par Pharmaceutical, Inc.